Bioshares featured LBT in their newsletter last week, rating it a "Speculative Buy Class A", with FDA approval expected "later in the year", much longer than most expect. The information appeared to be derived from a discussion with Guthrie so maybe she was going on an absolute worst case scenario. LBT likely a sleeper until approval comes through but would have to be a big pop given the current valuation.
The article pointed out that bioMerieux and BectonDickinson are both working on similar instrumentation, however the LBT-Hettich JV is about two years ahead. BD markets a product currently that only takes images and pairs it with an automated streaker system with incubator that retails for > $2 million. LBT's system will sell for US$100-200K but the incubator costs an additional $0.3MM; the systems are targeted to smaller labs which make up a vast majority of the market.
The other thing to look forward to is a distributor(s) for the system, where there has been very keen interest (might be a single global or several distributors). Given BD and BioM have their own systems in development I would guess multiple distributors may be a better longer term option which would allow them to ensure they have the best representation for each region (bioM was/is pretty poor in the US).
- Forums
- ASX - By Stock
- FDA Approval
Bioshares featured LBT in their newsletter last week, rating it...
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
|
|||||
Last
1.4¢ |
Change
-0.001(3.45%) |
Mkt cap ! $22.83M |
Open | High | Low | Value | Volume |
1.4¢ | 1.4¢ | 1.3¢ | $26.39K | 1.891M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 5685833 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 5685833 | 0.013 |
4 | 840000 | 0.012 |
4 | 376500 | 0.011 |
2 | 550000 | 0.010 |
1 | 50000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 50000 | 1 |
0.015 | 1307999 | 2 |
0.016 | 969333 | 4 |
0.017 | 720000 | 3 |
0.018 | 1195336 | 7 |
Last trade - 14.31pm 30/08/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online